Gink­go BioWorks picks up an­tibi­otics ef­fort with Roche where Warp Dri­ve Bio left off

When Rev­o­lu­tion Med­i­cines ab­sorbed fel­low Third Rock start­up Warp Dri­ve Bio in­to its op­er­a­tions last Oc­to­ber — then new­ly tran­si­tioned from an­ti­fun­gal to on­col­o­gy — the ex­ec …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.